TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from China NT Pharma Group Co., Ltd. ( (HK:1011) ) is now available.
China NT Pharma Group Co., Ltd. announced that it is assisting Hong Kong Government Authorities in an investigation related to a contract with an independent third party. The company clarified that this investigation does not affect its daily operations. Following the announcement, trading of the company’s shares, which was temporarily halted, is set to resume. This development highlights the company’s transparency and commitment to regulatory compliance, ensuring minimal disruption to its stakeholders.
The most recent analyst rating on (HK:1011) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China NT Pharma Group Co., Ltd. stock, see the HK:1011 Stock Forecast page.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its efforts in providing healthcare solutions and has a significant presence in the Asian market.
Average Trading Volume: 1,096,953
Technical Sentiment Signal: Buy
Current Market Cap: HK$525.9M
Learn more about 1011 stock on TipRanks’ Stock Analysis page.